Intestinal fatty acid binding protein (I-FABP) as a promising test for Crohn's disease: A preliminary study

Clinical Laboratory

Volumn 61, Issue 1-2, 2015, Pages 87-91

  Sarikaya, Murat ^a   Ergül, Bilal ^a   Doʇan, Zeynal ^a   Filik, Levent ^a   Can, Murat ^b   Arslan, Latife ^a  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b ZONGULDAK KARAELMAS UNIVERSITY   (Turkey)

Author keywords

Crohn's disease; Crohn's disease activity index; I FABP

Indexed keywords

C REACTIVE PROTEIN; FATTY ACID BINDING PROTEIN 2; BIOLOGICAL MARKER; FATTY ACID BINDING PROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CROHN DISEASE; CROHN DISEASE ACTIVITY INDEX; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; PROSPECTIVE STUDY; REMISSION; BLOOD; CASE CONTROL STUDY; CLINICAL TRIAL; MIDDLE AGED; PILOT STUDY; SEVERITY OF ILLNESS INDEX;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CROHN DISEASE; FATTY ACID-BINDING PROTEINS; FEMALE; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 84924765232     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: 10.7754/Clin.Lab.2014.140518     Document Type: Article

References (16)

1. Billmann-Born S, Lipinski S, Bock J, Till A, Rosenstiel P, Schreiber S. The complex interplay of NOD-like receptors and the autophagy machinery in the pathophysiology of Crohn disease. Eur J Cell Biol 2011;90(6-7):593-602.
2. Louis E, Collard A, Oger AF, Degroote E, Aboul Nasr El Yafi FA, Belaiche J. Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease. Gut 2001;49(6):777-82.
3. Higgens CS, Allan RN. Crohn's disease of the distal ileum. Gut 1980;21:933-40.
4. Pelsers MM, Hermens WT, Glatz JF. Fatty acid-binding proteins as plasma markers of tissue injury. Clin Chim Acta 2005 Feb;352 (1-2):15-35.
5. Funaoka H, Kanda T, Fujii H. Intestinal fatty acid-binding protein (I-FABP) as a new biomarker for intestinal diseases. Rinsho Byori 2010;58(2):162-8.
6. Wiercinska-Drapalo A, Jaroszewicz J, Siwak E, Pogorzelska J, Prokopowicz D. Intestinal fatty acid binding protein (I-FABP) as a possible biomarker of ileitis in patients with ulcerative colitis. Regul Pept 2008 Apr 10;147(1-3):25-8.
7. Riddell RH. Pathology of idiopathic inflammatory bowel disease. In: Kirsner JB, ed. Inflammatory bowel disease, Philadelphia: WB Saunders; 2000:427-52.
8. Derikx JP, Luyer MD, Heineman E, Buurman WA. Non-invasive markers of gut wall integrity in health and disease. World J Gastroenterol 2010;16(42):5272-9.
9. Kanda T, Tsukahara A, Ueki K, et al. Diagnosis of Ischemic Small Bowel Disease by Measurement of Serum Intestinal Fatty Acid-Binding Protein in Patients with Acute Abdomen: A Multicenter, Observer-Blinded Validation Study. J Gastroenterol 2011;46(4):492-500.
10. Kanda T, Fujii TH, Fujita M, Sakai Y, Ono T, Hatakeyama K. Intestinal Fatty Acid-Binding Protein is Available for Diagnosis of Intestinal Ischaemia: Immunochemical Analysis of Two Patients with Ischaemic Intestinal Diseases. Gut 1995;36(5):788-91.
11. Kanda T, Fujii H, Tani T, et al. Intestinal Fatty Acid-binding Protein Is a Useful Diagnostic Marker for Mesenteric Infarction in Humans. Gastroenterology 1996;110(2):339-43.
12. Gollin G, Marks C, Marks WH. Intestinal fatty acid-binding protein in serum and urine reflects early ischemic injury to the small bowel. Surgery 1993;113:545-51.
13. Andersen LW, Landow L, Baek L, Jansen E, Baker S. Association between gastric intramucosal pH and splanchnic endotoxin, antibody to endotoxin, and tumor necrosis factor alpha concentrations in patients undergoing cardiopulmonary bypass. Crit Care Med 1993;21:210-7.
14. Glatz JF, van der Vusse GJ. Cellular fatty acid-binding proteins: their function and physiological significance. Prog Lipid Res 1996;35:243-82.
15. Nielsen OH, Vainer B, Madsen SM, et al: Established and emerging biological activity markers of inflammatory bowel disease. Am J Gastroenterol 2000;95:359-67.
16. Vermeire S, Van Assche G, Rutgeerts P. Laboratory markers in IBD: useful, magic, or unnecessary toys? Gut 2006 Mar;55(3): 426-31.